An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients

Longo DL (2016) Harrison’s hematology and oncology. McGraw-Hill Education, New York, pp 82–94

Google Scholar 

Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A (2020) The changing epidemiology of the ageing thalassaemia populations: a position statement of the Thalassaemia International Federation. Eur J Haematol 105:16–23

Article  PubMed  Google Scholar 

Wahidiyat PA, Sari TT, Rahmartani LD, Setianingsih I, Iskandar SD, Pratanata AM, Yapiy I, Yosia M, Tricta F (2020) An insight into Indonesian current thalassaemia care and challenges. ISBT Sci Ser 15:334–341

Article  Google Scholar 

Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V (2014) Guidelines for the management of transfusion dependent thalassaemia (TDT)

Ibrahim H, Hassan A, George E, Goh A (2009) (2009) Management of transfusion dependent Thalassaemia health technology assessment section MDD. CPG Secretariat, Putrajaya, pp 1–21

Google Scholar 

Hershko C (2010) Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 1202:1–9

Article  CAS  PubMed  Google Scholar 

Vichinsky EP (1998) The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 850:344–348

Article  CAS  PubMed  Google Scholar 

Hashemieh M, Azarkeivan A, Radfar M, Saneifard H, Hosseini-Zijoud SM, Noghabaei G, Yaseri M (2014) Prevalence of osteoporosis among thalassemia patients from Zafar adult thalassemia clinic Iran. Iran J Blood Cancer 6:143–148

Google Scholar 

Atmakusuma TD, Tenggara JB (2021) Correlation of transferrin saturation and serum ferritin with bone mass density in adult transfusion dependent beta-thalassemia patients. J Blood Med 12:827–832

Article  PubMed  PubMed Central  Google Scholar 

Stefanopoulos D, Papaioannou NA, Papavassiliou AG, Mastorakos G, Vryonidou A, Michou A, Dontas IA, Lyritis G, Kassi E, Tournis S (2018) A contemporary therapeutic approach to bone disease in beta-thalassemia-a review. J Frailty Sarcopenia Falls 3:13

Article  PubMed  PubMed Central  Google Scholar 

Inati A, Noureldine MA, Mansour A, Abbas HA (2015) Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment. BioMed Res Int. https://doi.org/10.1155/2015/813098

Article  PubMed  PubMed Central  Google Scholar 

Solomon L, Warwick D, Nayagam S (2010) Apley’s system of orthopaedics and fractures, CRC press

Rosen HN, Rosen C, Mulder (2014) Use of biochemical markers of bone turnover in osteoporosis. Up-to-date, version, 14

Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 111:902–907

CAS  PubMed  Google Scholar 

Mirhosseini NZ, Shahar S, Ghayour-Mobarhan M, Banihashem A, Kamaruddin NA, Hatef MR, Esmaili HA (2013) Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Miner Metab 31:468–476

Article  CAS  PubMed  Google Scholar 

Galea GL, Lanyon LE, Price JS (2017) Sclerostin’s role in bone’s adaptive response to mechanical loading. Bone 96:38–44

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo J, Smith T, Reeves S, Halsey L, Huber J (2018) Effects of BMI on bone loading due to physical activity. J Appl Biomech 34:7

Article  CAS  PubMed  Google Scholar 

Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, Lim SY, Yoo KH, Jung KS, Kim YK, Rhee CK (2017) Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chron Obstr Pulm Dis 12:2465–2475

Article  CAS  Google Scholar 

Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry. J Clin Densitom 16:455–466

Article  PubMed  Google Scholar 

Wallach JB (2007) Interpretation of diagnostic tests, Lippincott Williams & Wilkins

Research., M.F.f.M.E.a. NTX-Telopeptide, Urine. Available online: https://pediatric.testcatalog.org/show/NTXPR (Accessed on October 17).

Dawson-Hughes B, Harris SS, Ceglia L, Palermo NJ (2014) Serum sclerostin levels vary with season. J Clin Endocrinol Metab 99:E149-152. https://doi.org/10.1210/jc.2013-3148

Article  PubMed  Google Scholar 

Clarke BL, Drake MT (2013) Clinical utility of serum sclerostin measurements. Bonekey Rep 2:361. https://doi.org/10.1038/bonekey.2013.95

Article  PubMed  PubMed Central  Google Scholar 

Nakhakes C, Jaruluxananan S, Saengsuda Y, Saengsuda S (2015) Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospital. Asian Biomed 9:169–174. https://doi.org/10.5372/1905-7415.0902.383

Article  Google Scholar 

Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res 29:2468–2473

Article  CAS  PubMed  Google Scholar 

Lidoriki I, Stavrou G, Schizas D, Frountzas M, Fotis L, Kapelouzou A, Kokkota S, Fyntanidou B, Kotzampassi K (2022) Nutritional status in a sample of patients with β-thalassemia major. Cureus. https://doi.org/10.7759/cureus.27985

Article  PubMed  PubMed Central  Google Scholar 

Turner AG, Anderson PH, Morris HA (2012) Vitamin D and bone health. Scand J Clin Lab Invest 72:65–72

CAS  Google Scholar 

Collins D, Jasani C, Fogelman I, Swaminathan R (1998) Vitamin D and bone mineral density. Osteoporos Int 8:110–114. https://doi.org/10.1007/bf02672505

Article  CAS  PubMed  Google Scholar 

Kothimira VK, Kumar A, Richhele LR, Sood N, Gulati A (2020) An evaluation of bone health parameters in regularly transfused beta-thalassemia major patients. J Pediatr Hematol Oncol 42:381–385. https://doi.org/10.1097/mph.0000000000001733

Article  PubMed  Google Scholar 

Shah S, Shah J, Vyas BR (2020) Assessment of bone mineral density in multi-transfused thalassemia patients in a tertiary care hospital. Int J Pediatr Res 7(1):32–38

Article  Google Scholar 

Lin JP, Shi ZJ, Shen NJ, Wang J, Li ZM, Xiao J (2016) N-terminal telopeptides of type I collagen and bone mineral density for early diagnosis of nonunion: an experimental study in rabbits. Indian J Orthop 50:421–426. https://doi.org/10.4103/0019-5413.185608

Article  PubMed  PubMed Central  Google Scholar 

Arab-Zozani M, Kheyrandish S, Rastgar A, Miri-Moghaddam E (2021) A systematic review and meta-analysis of stature growth complications in β-thalassemia major patients. Ann Glob Health 87:48

Article  PubMed  PubMed Central  Google Scholar 

Argyropoulou MI, Metafratzi Z, Kiortsis DN, Bitsis S, Tsatsoulis A, Efremidis S (2000) T2 relaxation rate as an index of pituitary iron overload in patients with β-Thalassemia Major. Am J Roentgenol 175:1567–1569. https://doi.org/10.2214/ajr.175.6.1751567

Article  CAS  Google Scholar 

Yang WP, Chang HH, Li HY, Lai YC, Huang TY, Tsai KS, Lin KH, Lin DT, Jou ST, Lu MY et al (2020) Iron Overload associated endocrine dysfunction leading to lower bone mineral density in Thalassemia major. J Clin Endocrinol Metab 105:e1015–e1024. https://doi.org/10.1210/clinem/dgz309

Article  Google Scholar 

El-Nashar M, Mortagy AK, El-Beblawy NM, El-Gohary E, Kamel IM, Rashad M, Mouharam WA (2017) Parathyroid hormone in pediatric patients with β-thalassemia major and its relation to bone mineral density; a case control study. Egypt J Med Hum Genet 18:75–78

Article  Google Scholar 

Morin S, Tsang JF, Leslie WD (2009) Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int 20:363–370. https://doi.org/10.1007/s00198-008-0688-x

Article  CAS  PubMed  Google Scholar 

Lloyd JT, Alley DE, Hawkes WG, Hochberg MC, Waldstein SR, Orwig DL (2014) Body mass index is positively associated with bone mineral density in US older adults. Arch Osteoporos 9:175. https://doi.org/10.1007/s11657-014-0175-2

Article  PubMed  Google Scholar 

Modagan P, Chand L, Menon G, Aruna L, Silambanan S (2022) Association of N-terminal telopeptide-1 with BMD in patients with osteopenia and osteoporosis. Hayчныe peзyльтaты биoмeдицинcкиx иccлeдoвaний 8:82–90

Comments (0)

No login
gif